The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Open accessAbstract
Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD‐D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD‐D. The Task Force members were assigned to sub‐committees and performed a systematic review of the literature, based on pre‐defined selection criteria, in order to identify the epidemiological, clinical, auxillary, and pathological features of PD‐D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point‐prevelance is close to 30%, older age and akinetic‐rigid form are associated with higher risk. PD‐D is characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body‐type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD‐D are proposed. © 2007 Movement Disorder Society
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Final diagnoses were based on internationally established criteria [12, 46, 49–52].”
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714
Self-citationPrevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219
Self-citationSydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,006
González-Latapí, P., Bayram, E., Litvan, I., & Marras, C. (2021) · Behavioral Sciences · doi:10.3390/bs11050074 · Cited by 128
Self-citationVisual complaints and visual hallucinations in Parkinson's disease
Urwyler, P., Nef, T., Killen, A., Collerton, D., Thomas, A. J., Burn, D. J., McKeith, I. G., & Mosimann, U. P. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.12.009 · Cited by 107
Self-citationFritz, N. E., Kegelmeyer, D. A., Kloos, A., Linder, S., Park, A., Kataki, M., Adeli, A., Agrawal, P., Scharre, D. W., & Kostyk, S. K. (2016) · Gait & Posture · doi:10.1016/j.gaitpost.2016.08.009 · Cited by 104
Reduced occipital GABA in Parkinson disease with visual hallucinations
Firbank, M. J., Parikh, J., Murphy, N., Killen, A., Allan, C. L., Collerton, D., Blamire, A. M., & Taylor, J.-P. (2018) · Neurology · doi:10.1212/wnl.0000000000006007 · Cited by 103
Mild cognitive impairment and cognitive reserve in Parkinson’s disease
Poletti, M., Emre, M., & Bonuccelli, U. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.03.013 · Cited by 116
Self-citationHippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease
Kandiah, N., Zainal, N. H., Narasimhalu, K., Chander, R. J., Ng, A. Y. T., Mak, E., Au, W. L., Sitoh, Y. Y., Nadkarni, N. V., & Tan, L. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.08.024 · Cited by 105
Yang, W., Chen, Y., Liu, H., & Qu, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2356 · Cited by 105
Narme, P., Mouras, H., Roussel, M., Duru, C., Krystkowiak, P. C., & Godefroy, O. (2013) · Neuropsychology · doi:10.1037/a0031522 · Cited by 104
Effects of cognitive training in Parkinson's disease: A randomized controlled trial
Petrelli, A., Kaesberg, S., Barbe, M. T., Timmermann, L., Fink, G. R., Kessler, J., & Kalbe, E. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.08.023 · Cited by 104
Babiloni, C., Pandis, M. F. D., Vecchio, F., Buffo, P., Sorpresi, F., Frisoni, G. B., & Rossini, P. M. (2011) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.03.029 · Cited by 104
Santangelo, G., Barone, P., Cuoco, S., Raimo, S., Pezzella, D., Picillo, M., Erro, R., Moccia, M., Pellecchia, M. T., Amboni, M., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7498-1 · Cited by 104
Cerebral Metabolic Dysfunction in Patients with Dementia with Lewy Bodies and Visual Hallucinations
Perneczky, R., Drzezga, A. E., Boecker, H., Förstl, H., Kurz, A., & Häussermann, P. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000132084 · Cited by 101
Factor, S. A., Steenland, N. K., Higgins, D. S., Molho, E., Kay, D. M., Montimurro, J. S., Rosen, A. R., Zabetian, C. P., & Payami, H. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.222042 · Cited by 103
Betrouni, N., Delval, A., Chaton, L., Defebvre, L., Duits, A., Moonen, A. J. H., Leentjens, A. F. G., & Dujardin, K. (2018) · Movement Disorders · doi:10.1002/mds.27528 · Cited by 108
Compta, Y., Valente, T., Saura, J., Segura, B., Iranzo, Á., Serradell, M., Junqué, C., Tolosa, E. S., Valldeoriola, F., Muñoz, E., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7560-z · Cited by 108
Self-citationBehavioural disorders, disability and quality of life in Parkinson's disease
Leroi, I., Ahearn, D., Andrews, M., McDonald, K. R., Byrne, E. J., & Burns, A. S. (2011) · Age and Ageing · doi:10.1093/ageing/afr078 · Cited by 105
Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution
Ferman, T. J., Aoki, N., Boeve, B. F., Aakre, J. A., Kantarci, K., Graff‐Radford, J., Parisi, J. E., van Gerpen, J. A., Graff‐Radford, N. R., Uitti, R. J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009763 · Cited by 100
Self-citationWesnes, K. A., Aarsland, D., Ballard, C. G., & Londos, E. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4109 · Cited by 102
Self-citationAβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia
Petrou, M., Bohnen, N. I., Müller, M. L. T. M., Koeppe, R. A., Albin, R. L., & Frey, K. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182698d4a · Cited by 102
Deep Brain Stimulation and Cognitive Decline in Parkinson’s Disease: A Clinical Review
Massano, J., & Garrett, C. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00066 · Cited by 99
Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
Broeders, M., Velseboer, D. C., de Bie, R. M. A., Speelman, J. D., Muslimović, D., Post, B., de Haan, R. J., & Schmand, B. A. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000295 · Cited by 99
Early-onset dementias: diagnostic and etiological considerations
Masellis, M., Sherborn, K., Rosa‐Neto, P., Sadovnick, A. D., Hsiung, G. R., Black, S. E., Prasad, S., Williams, M., & Gauthier, S. G. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt197 · Cited by 102
Self-citationCourse of neuropsychiatric symptoms in dementia: 5-year longitudinal study
Vik‐Mo, A. O., Giil, L. M., Ballard, C., & Aarsland, D. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4933 · Cited by 99
Self-citationManagement of Motor and Non-Motor Symptoms in Parkinson’s Disease
Sprenger, F., & Poewe, W. H. (2013) · CNS Drugs · doi:10.1007/s40263-013-0053-2 · Cited by 109
Self-citationOlfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease
Domellöf, M. E., Lundin, K., Edström, M., & Forsgren, L. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.017 · Cited by 99
EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer’s disease
Schumacher, J., Thomas, A. J., Peraza, L. R., Firbank, M., Cromarty, R. A., Hamilton, C. A., Donaghy, P. C., O'Brien, J. T., & Taylor, J. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00613-6 · Cited by 99
Cognitive stimulation and cognitive results in older adults: A systematic review and meta-analysis
Gómez‐Soria, I., Iguacel, I., Aguilar‐Latorre, A., Peralta, P., Latorre, E., Cuenca‐Zaldívar, J. N., & Calatayud, E. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104807 · Cited by 111
Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation
Sevin, M., Kutalik, Z., Bergman, S., Vercelletto, M., Renou, P., Lamy, E., Vingerhoets, F. J. G., Virgilio, G. D., Boisseau, P., Bezieau, S., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.065953 · Cited by 99
Brooks, D. J. (2009) · Movement Disorders · doi:10.1002/mds.22581 · Cited by 97
Visual exploration in Parkinson’s disease and Parkinson’s disease dementia
Archibald, N. K., Hutton, S. B., Clarke, M. W., Mosimann, U. P., & Burn, D. J. (2013) · Brain · doi:10.1093/brain/awt005 · Cited by 96
Self-citationO’Callaghan, C., Hezemans, F. H., Ye, R., Rua, C., Jones, P. S., Murley, A. G., Holland, N., Regenthal, R., Tsvetanov, K. A., Wolpe, N., et al. (2021) · Brain · doi:10.1093/brain/awab142 · Cited by 99
Brønnick, K., Norwegian ParkWest Study Group, Alves, G. W., Aarsland, D., Tysnes, O., & Larsen, J. P. (2010) · Neuropsychology · doi:10.1037/a0020857 · Cited by 108
Self-citationReduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study
Pitcher, T. L., Melzer, T. R., MacAskill, M. R., Graham, C., Livingston, L., Keenan, R. J., Watts, R., Dalrymple‐Alford, J. C., & Anderson, T. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-17 · Cited by 98
Kulisevsky, J., de Bobadilla, R. F., Pagonabarraga, J., Martínez‐Horta, S., Campolongo, A., García‐Sánchez, C., Pascual‐Sedano, B., Nogué, R. R., & Villa-Bonomo, C. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.007 · Cited by 101
Bowen, M., Edgar, D. F., Hancock, B., Haque, S. M., Shah, R., Buchanan, S., Iliffe, S., Maskell, S., Pickett, J., Taylor, J., et al. (2016) · Health Services and Delivery Research · doi:10.3310/hsdr04210 · Cited by 95
Alpha Power and Functional Connectivity in Cognitive Decline: A Systematic Review and Meta-Analysis
Lejko, N., Larabi, D. I., Herrmann, C. S., Aleman, A., & Ćurĉić‐Blake, B. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200962 · Cited by 112
The prevalence and causes of younger onset dementia in Eastern Sydney, Australia
Withall, A., Draper, B., Seeher, K. M., Brodaty, H., Koopmans, R., & Rosness, T. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001835 · Cited by 97
Ruffmann, C., Calboli, F. C. F., Bravi, I., Gveric, D. O., Curry, L. K., de Smith, A. J., Pavlou, S., Buxton, J. L., Blakemore, A. I. F., Takousis, P., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12294 · Cited by 100
DSM-5 and Mental Disorders in Older Individuals
Sachdev, P. S., Mohan, A., Taylor, L., & Jeste, D. V. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000090 · Cited by 100
Graph theory network function in Parkinson’s disease assessed with electroencephalography
Utianski, R. L., Caviness, J. N., van Straaten, E. C. W., Beach, T. G., Dugger, B. N., Shill, H. A., Driver‐Dunckley, E. D., Sabbagh, M. N., Mehta, S. H., Adler, C. H., et al. (2016) · Clinical Neurophysiology · doi:10.1016/j.clinph.2016.02.017 · Cited by 104
Zhang, Y. (2017) · Parkinson s Disease · doi:10.1155/2017/6209703 · Cited by 96
Beyond tremor and rigidity: non-motor features of Parkinson’s disease
Löhle, M., Storch, A., & Reichmann, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0274-1 · Cited by 99
Garn, H., Coronel, C., Waser, M., Caravias, G., & Ransmayr, G. N. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1699-6 · Cited by 113
The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases
Cummings, J. (2021) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.07.011 · Cited by 96
Self-citationCraggs, L., Yamamoto, Y., Deramecourt, V., & Kalaria, R. N. (2014) · Brain Pathology · doi:10.1111/bpa.12177 · Cited by 96
Predicting dementia development in Parkinson's disease using Bayesian network classifiers
Morales, D. A., Vives‐Gilabert, Y., Gómez‐Ansón, B., Bengoetxea, E., Larrañaga, P., Bielza, C., Pagonabarraga, J., Kulisevsky, J., Corcuera‐Solano, I., & Delfino, M. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.06.001 · Cited by 96
Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology
Skogseth, R. E., Hortobágyi, T., Soennesyn, H., Chwiszczuk, L. J., Ffytche, D. H., Rongve, A., Ballard, C. G., & Aarsland, D. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170274 · Cited by 96
Self-citationAssessment of cognition in early dementia
Silverberg, N. B., Ryan, L. M., Carrillo, M. C., Sperling, R. A., Petersen, R. C., Posner, H. B., Snyder, P. J., Hilsabeck, R. C., Gallagher, M., Raber, J., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.001 · Cited by 109
Self-citationA blood screening test for Alzheimer's disease
O’Bryant, S. E., Edwards, M., Johnson, L. A., Hall, J. R., Villarreal, A. E., Britton, G. B., Quiceno, M. E., Cullum, C. M., & Graff‐Radford, N. R. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.06.004 · Cited by 99
α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease
Guella, I., Evans, D. M., Szu‐Tu, C., Nosova, E., Bortnick, S., SNCA Cognition Study Group, Goldman, J. G., Dalrymple‐Alford, J. C., Geurtsen, G. J., Litvan, I., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24664 · Cited by 94
Self-citationRecent advances in Lewy body dementia: A comprehensive review
Prasad, S., Katta, M. R., Abhishek, S., Sridhar, R., Valisekka, S. S., Hameed, M., Kaur, J., & Walia, N. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101441 · Cited by 100
Biomarkers of cognitive decline in Parkinson's disease
Lin, C., & Wu, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.010 · Cited by 100
Lopes, R., Delmaire, C., Defebvre, L., Moonen, A. J. H., Duits, A., Hofman, P. A. M., Leentjens, A. F. G., & Dujardin, K. (2016) · Human Brain Mapping · doi:10.1002/hbm.23474 · Cited by 91
Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
Weil, R. S., Costantini, A. A., & Schrag, A. E. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0823-9 · Cited by 94
Clinical implications of early caudate dysfunction in Parkinson’s disease
Pasquini, J., Durcan, R., Wiblin, L., Stokholm, M. G., Rochester, L., Brooks, D. J., Burn, D. J., & Pavese, N. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320157 · Cited by 93
Self-citationTargeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer’s Disease
Oeckl, P., Halbgebauer, S., Anderl‐Straub, S., Arnim, C. A. F. V., Diehl‐Schmid, J., Froelich, L., Grimmer, T., Hausner, L., Denk, J., Jahn, H., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00824 · Cited by 93
Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease
Blommer, J. M., Pitcher, T. L., Mustapić, M., Eren, E., Yao, P. J., Vreones, M. P., Pucha, K. A., Dalrymple‐Alford, J. C., Shoorangiz, R., Meissner, W. G., et al. (2022) · Brain · doi:10.1093/brain/awac258 · Cited by 95
Influence of White Matter Hyperintensities on the Cognition of Patients With Parkinson Disease
Lee, S., Kim, J., Yoo, J.-Y., Song, I., Kim, B., Jung, S. L., Yang, D., Kim, Y.-I., Jeong, D., & Lee, K.-S. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181d71a13 · Cited by 93
Cognitive training in Parkinson's disease reduces cognitive decline in the long term
Petrelli, A., Kaesberg, S., Barbe, M. T., Timmermann, L., Rosen, J. B., Fink, G. R., Kessler, J., & Kalbe, E. (2014) · European Journal of Neurology · doi:10.1111/ene.12621 · Cited by 100
Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment
Goldman, J. G., Holden, S. K., Litvan, I., McKeith, I. G., Stebbins, G. T., & Taylor, J. (2018) · Movement Disorders · doi:10.1002/mds.27323 · Cited by 93
Self-citationPark, Y. W., Shin, N., Chung, S. J., Kim, J., Lim, S. M., Lee, P. H., Lee, S., & Ahn, K. J. (2019) · Movement Disorders · doi:10.1002/mds.27798 · Cited by 93
Long-Term Dementia Risk in Parkinson Disease
Gallagher, J., Gochanour, C., Caspell‐Garcia, C., Dobkin, R. D., Aarsland, D., Alcalay, R. N., Barrett, M. J., Chahine, L. M., Chen‐Plotkin, A. S., Coffey, C. S., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209699 · Cited by 98
Self-citationApathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study
Pedersen, K. F., Alves, G. W., Brønnick, K., Aarsland, D., Tysnes, O., & Larsen, J. P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5297-x · Cited by 96
Self-citationLewy body dementia: the impact on patients and caregivers
Zweig, Y., & Galvin, J. E. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt251 · Cited by 91
Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide
McKeith, I. G. (2007) · Practical Neurology · doi:10.1136/jnnp.2007.134163 · Cited by 91
Self-citationJahanshahi, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-36346-8_9 · Cited by 92
Sex effects on brain structure in de novo Parkinson’s disease: a multimodal neuroimaging study
Tremblay, C., Abbasi, N., Zeighami, Y., Yau, Y. H. C., Dadar, M., Rahayel, S., & Dagher, A. (2020) · Brain · doi:10.1093/brain/awaa234 · Cited by 91
Ruppert, M. C., Greuel, A., Freigang, J., Tahmasian, M., Maier, F., Hammes, J., van Eimeren, T., Timmermann, L., Tittgemeyer, M., Drzezga, A. E., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25393 · Cited by 91
Treatment of Parkinson’s Disease with Cognitive Impairment: Current Approaches and Future Directions
Sun, C. E., & Armstrong, M. J. (2021) · Behavioral Sciences · doi:10.3390/bs11040054 · Cited by 95
Pereira, J. B., Kumar, A., Hall, S., Palmqvist, S., Stomrud, E., Bali, D., Parchi, P., Mattsson, N., Janelidze, S., & Hansson, O. (2023) · Nature Aging · doi:10.1038/s43587-023-00478-y · Cited by 95
Jahanshahi, M. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00118 · Cited by 101
Management of psychiatric and cognitive complications in Parkinson’s disease
Weintraub, D. A., Aarsland, D., Biundo, R., Dobkin, R. D., Goldman, J. G., & Lewis, S. J. G. (2022) · BMJ · doi:10.1136/bmj-2021-068718 · Cited by 91
Self-citationRektorová, I., Krajčovičová, L., Mareček, R., & Mikl, M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334765 · Cited by 90
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
Pont‐Sunyer, C., Iranzo, Á., Gaig, C., Fernández‐Arcos, A., Vilas, D., Valldeoriola, F., Compta, Y., Fernández‐Santiago, R., Fernández, M., Bayés, À., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132368 · Cited by 89
Self-citationBabiloni, C., Percio, C. D., Lizio, R., Noce, G., Lopez, S., Soricelli, A., Ferri, R., Nobili, F. M., Arnaldi, D., Famà, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.023 · Cited by 90
Self-citationPimavanserin: Potential Treatment For Dementia-Related Psychosis
Cummings, J. L., Ballard, C. G., Tariot, P. N., Owen, R., Foff, E. P., Youakim, J. M., Norton, J., & Stankovic, S. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.29 · Cited by 92
Self-citationNilsson, M., Szczepankiewicz, F., van Westen, D., & Hansson, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141825 · Cited by 89
The morbid anatomy of dementia in Parkinson’s disease
Kalaitzakis, M. E., & Pearce, R. K. B. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0597-x · Cited by 90
Pirogovsky, E., Schiehser, D. M., Obtera, K. M., Burke, M. M., Lessig, S. L., Song, D. D., Litvan, I., & Filoteo, J. V. (2014) · Neuropsychology · doi:10.1037/neu0000045 · Cited by 89
Self-citationPeople with Parkinson's disease and normal MMSE score have a broad range of cognitive performance
Burdick, D. J., Cholerton, B., Watson, G. S., Siderowf, A. D., Trojanowski, J. Q., Weintraub, D. A., Ritz, B. R., Rhodes, S. L., Rausch, R., Factor, S. A., et al. (2014) · Movement Disorders · doi:10.1002/mds.25924 · Cited by 89
Structural Brain Connectome and Cognitive Impairment in Parkinson Disease
Galantucci, S., Agosta, F., Stefanova, E. D., Basaia, S., van den Heuvel, M. P., Stojković, T., Canu, E., Stanković, I., Marković, V., Copetti, M., et al. (2016) · Radiology · doi:10.1148/radiol.2016160274 · Cited by 90
Neuroimaging in Lewy body dementia
Yousaf, T., Dervenoulas, G., Valkimadi, P., & Politis, M. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8892-x · Cited by 98
Millan, M. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.002 · Cited by 92
Milestones in atypical and secondary Parkinsonisms
Wenning, G. K., Litvan, I., & TOLOSA, E. S. (2011) · Movement Disorders · doi:10.1002/mds.23713 · Cited by 88
Self-citationMild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism
Pappatà, S., Santangelo, G., Aarsland, D., Vicidomini, C., Longo, K., Brønnick, K., Amboni, M., Erro, R., Vitale, C., Caprio, M. G., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182315259 · Cited by 89
Self-citationHopes, L., Grolez, G., Moreau, C., Lopes, R., Ryckewaert, G., Carrière, N., Auger, F., Laloux, C., Pétrault, M., Devedjian, J.-C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147947 · Cited by 88
Zerr, I., Schmitz, M., Karch, A., Villar‐Piqué, A., Kanata, Ε., Golańska, E., Lucena, D. D., Karsanidou, A., Hermann, P., Knipper, T., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.12.008 · Cited by 88
Changes in insomnia subtypes in early Parkinson disease
Tholfsen, L. K., Larsen, J. O., Schulz, J., Tysnes, O., & Gjerstad, M. D. (2016) · Neurology · doi:10.1212/wnl.0000000000003540 · Cited by 87
Nicoletti, A. S. Q., Luca, A., Baschi, R., Cicero, C. E., Mostile, G., Davì, M., Pilati, L., Restivo, V., Zappia, M., & Monastero, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00021 · Cited by 88
Patterns of cortical thinning in nondemented Parkinson's disease patients
Uribe, C., Segura, B., Baggio, H. C., Abós, A., Martı́, M. J., Valldeoriola, F., Compta, Y., Bargalló, N., & Junqué, C. (2016) · Movement Disorders · doi:10.1002/mds.26590 · Cited by 86
Cash, T. V., Ekouevi, V. S., Kilbourn, C., & Lageman, S. K. (2016) · Mindfulness · doi:10.1007/s12671-015-0452-1 · Cited by 86
Pettorruso, M., Martinotti, G., Fasano, A. A., Loria, G., Nicola, M. D., Risio, L. D., Ricciardi, L., Conte, G., Janiri, L., & Bentivoglio, A. R. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.013 · Cited by 88
The reorganization of functional architecture in the early-stages of Parkinson's disease
Tuovinen, N., Seppi, K., de Pasquale, F., Müller, C. F., Nocker, M., Schocke, M. F. H., Gizewski, E. R., Kremser, C., Wenning, G. K., Poewe, W. H., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.013 · Cited by 89
Self-citationImproving the clinical detection of Lewy body dementia with the Lewy body composite risk score
Galvin, J. E. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.004 · Cited by 88
Lee, D. R., McKeith, I. G., Mosimann, U. P., Nodiyal, A. G., Grayson, L., Wilson, B., & Thomas, A. J. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.072 · Cited by 84
Self-citationBorroni, B., Premi, E., Formenti, A., Turrone, R., Alberici, A., Cottini, E., Rizzetti, M. C., Gasparotti, R., & Padovani, A. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.013 · Cited by 90
Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease
Goldman, J. G., Bledsoe, I. O., Merkitch, D., Dinh, V., Bernard, B. A., & Stebbins, G. T. (2017) · Neurology · doi:10.1212/wnl.0000000000003764 · Cited by 85
Self-citationDo Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
Ardle, R. M., Galna, B., Donaghy, P. C., Thomas, A. J., & Rochester, L. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.4953 · Cited by 86
Mosley, P. E., Paliwal, S., Robinson, K., Coyne, T. J., Silburn, P. A., Tittgemeyer, M., Stephan, K. E., Perry, A., & Breakspear, M. J. (2020) · Brain · doi:10.1093/brain/awaa148 · Cited by 87
Progressive brain atrophy and clinical evolution in Parkinson’s disease
Filippi, M., Sarasso, E., Piramide, N., Stojković, T., Stanković, I., Basaia, S., Fontana, A., Tomić, A., Marković, V., Stefanova, E. D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102374 · Cited by 85
Metadata
- Authors
- Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., & Dubois, B.
- Affiliations
- Istanbul University (TR)
- Stavanger University Hospital (NO)
- King's College London (GB)
- Newcastle University (GB)
- Inserm (FR)
- Juntendo University (JP)
- UNSW Sydney (AU)
- University of California, Los Angeles (US)
- Mayo Clinic (US)
- McGill University Research Centre for Studies in Aging (CA)
- Rush University Medical Center (US)
- Tel Aviv University (IL)
- National Hospital for Neurology and Neurosurgery (GB)
- University of Louisville (US)
- Newcastle upon Tyne Hospital (GB)
- Icahn School of Medicine at Mount Sinai (US)
- Innsbruck Medical University (AT)
- University of Lisbon (PT)
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Emre, Murat
- ORCID
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2007-05-31
- Volume
- 22
- Issue
- 12
- Pages
- 1689-1707
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2166609052
- Cited by
- 3,027
- References
- 187
- Citations by year
- 2026: 141 · 2025: 203 · 2024: 192 · 2023: 174 · 2022: 253 · 2021: 215 · 2020: 202 · 2019: 189 · 2018: 173 · 2017: 153 · 2016: 177 · 2015: 151 · 2014: 161 · 2013: 157 · 2012: 137
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council (G0400074)
- National Institute on Aging (R01AG024040)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease dementia, clinical criteria, Lewy bodies, dementia prevalence, executive dysfunction, memory impairment, hallucinations, apathy, behavioral symptoms
- MeSH terms
- Dementia, Diagnosis, Differential, Humans, Neuropsychological Tests, Parkinson Disease, Severity of Illness Index, Task Performance and Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
